Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?

被引：0
|
作者：
J. M. P. W. U. Peeters
S. Sanders-van Wijk
S. Bektas
C. Knackstedt
P. Rickenbacher
F. Nietlispach
R. Handschin
M. T. Maeder
S. F. Muzzarelli
M. E. Pfisterer
H. P. Brunner-La Rocca
机构：
[1] Maastricht University Medical Center,Department of Cardiology
[2] CARIM,undefined
[3] University Hospital Bruderholz,undefined
[4] University Hospital Basel,undefined
[5] University Hospital Berne,undefined
[6] Kantonsspital St Gallen,undefined
[7] Fondazione Cardiocentro Ticino,undefined
来源：
Netherlands Heart Journal | 2014年 / 22卷
关键词：
Heart failure; NT-proBNP; Natriuretic peptide; Biomarkers; Cystatin-C; Hs-CRP; Hs-TnT; GDF-15;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 121
页数：6
相关论文
共 50 条
  • [41] Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials
    Ibrahim, Nasrien E.
    Gaggin, Hanna K.
    Konstam, Marvin A.
    Januzzi, James L., Jr.
    CIRCULATION-HEART FAILURE, 2016, 9 (09)
  • [42] Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin
    Palazzuoli, Alberto
    Masson, Serge
    Ronco, Claudio
    Maisel, Alan
    HEART FAILURE REVIEWS, 2014, 19 (02) : 267 - 284
  • [43] Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
    Bayes-Genis, Antoni
    Aimo, Alberto
    Jhund, Pardeep
    Richards, Mark
    de Boer, Rudolf A.
    Arfsten, Henrike
    Fabiani, Iacopo
    Lupon, Josep
    Anker, Stefan D.
    Gonzalez, Arantxa
    Castiglione, Vincenzo
    Metra, Marco
    Mueller, Christian
    Nunez, Julio
    Rossignol, Patrick
    Barison, Andrea
    Butler, Javed
    Teerlink, John
    Filippatos, Gerasimos
    Ponikowski, Piotr
    Vergaro, Giuseppe
    Zannad, Faiez
    Seferovic, Petar
    Rosano, Giuseppe
    Coats, Andrew J. S.
    Emdin, Michele
    Januzzi, James L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1767 - 1777
  • [44] Potential Biomarkers for Heart Failure Diagnostics and Management
    Tokmachev, Roman Evgenyevich
    Kravchenko, Andrey Yakovlevich
    Budnevsky, Andrey Valerievich
    Chernik, Tatiana Alexandrovna
    Tokmachev, Evgeny Viktorovich
    Shkatova, Yanina Sergeevna
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (04): : 1813 - 1816
  • [45] Prospective evaluation of an outpatient heart failure management program
    Hershberger, RE
    Ni, HY
    Nauman, DJ
    Burgess, D
    Toy, W
    Wise, K
    Dutton, D
    Crispell, K
    Vossler, M
    Everett, J
    JOURNAL OF CARDIAC FAILURE, 2001, 7 (01) : 64 - 74
  • [46] Practical outpatient management of worsening chronic heart failure
    Girerd, Nicolas
    Mewton, Nathan
    Tartiere, Jean-Michel
    Guijarro, Damien
    Jourdain, Patrick
    Damy, Thibaud
    Lamblin, Nicolas
    Bayes-Genis, Antoni
    Pellicori, Pierpaolo
    Januzzi, James L.
    Rossignol, Patrick
    Roubille, Francois
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 750 - 761
  • [47] Novel heart failure biomarkers: why do we fail to exploit their potential?
    Piek, Arnold
    Du, Weijie
    de Boer, Rudolf A.
    Sillje, Herman H. W.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2018, 55 (04) : 246 - 263
  • [48] Heart Failure Optimizing Recognition and Management in Outpatient Settings
    Neubauer, Brian E.
    Gray, Jeffery T.
    Hemann, Brian A.
    PRIMARY CARE, 2018, 45 (01): : 63 - 79
  • [49] Heart failure management: why evidence does not influence clinical practice
    Remme, WJ
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0I) : L15 - L21
  • [50] Clinical use of novel biomarkers in heart failure: towards personalized medicine
    Schmitter, Daniela
    Cotter, Gadi
    Voors, Adriaan A.
    HEART FAILURE REVIEWS, 2014, 19 (03) : 369 - 381
12345